JF

Jiping Fu

NA Novartis Ag: 21 patents #65 of 5,128Top 2%
NT Nikang Therapeutics: 13 patents #2 of 9Top 25%
📍 Danville, CA: #58 of 1,210 inventorsTop 5%
🗺 California: #14,433 of 386,348 inventorsTop 4%
Overall (All Time): #100,596 of 4,157,543Top 3%
34
Patents All Time

Issued Patents All Time

Showing 1–25 of 34 patents

Patent #TitleCo-InventorsDate
12415779 Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof Charles Cook, Yigang He, Yan Lou, Rongzhen Chen, Yan Dong 2025-09-16
12391642 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors Yan Lou, Yigang He 2025-08-19
12264167 Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors Yan Lou, Yigang He 2025-04-01
12171741 2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors Yan Lou, Yigang He 2024-12-24
12077506 Indane derivatives as hypoxia inducible factor-2(α) inhibitors Yan Lou, Yigang He 2024-09-03
11753366 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors Yan Lou, Yigang He 2023-09-12
11634382 Process of preparing 3-fluoro-5(((1R,2aR)-3,3,4,4-tetrafluoro-1,2a-dihydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)-oxy)benzonitrile Yan Lou, Yigang He, Yuetao SHI, Peng ZHOU, Xingxing LI 2023-04-25
11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors Yan Lou, Yigang He 2022-12-06
11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors Yan Lou, Yigang He 2022-10-04
11420936 Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases Yan Lou, Yigang He 2022-08-23
11267782 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors Yan Lou, Yigang He 2022-03-08
11234977 Fused tricyclic pyrazolo-dihydropyrazinyl-pyridone compounds as antivirals Wooseok Han, Xianming Jin, Keith B. Pfister, Joseph Michael Young 2022-02-01
11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors Yan Lou, Yigang He 2021-06-15
10975078 Fused indazole pyridone compounds as antivirals Wooseok Han, Subramanian Karur, Peichao Lu, Keith B. Pfister, Joseph Michael Young 2021-04-13
10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors Yan Lou, Yigang He 2021-01-19
10301312 Fused indazole pyridone compounds as antivirals Wooseok Han, Subramanian Karur, Peichao Lu, Keith B. Pfister, Joseph Michael Young 2019-05-28
10093673 Tetracyclic pyridone compounds as antivirals Xianming Jin, Patrick Lee, Peichao Lu, Joseph Michael Young 2018-10-09
10071973 Crystalline isoxazole hydroxamic acid compounds Siyi Jiang, Andreas Kordikowski, Zachary K. Sweeney 2018-09-11
10029994 Isoxazole hydroxamic acid compounds as LpxC inhibitors Xianming Jin, Subramanian Karur, Guillaume Lapointe, Ann Marie Madera, Zachary K. Sweeney 2018-07-24
9845325 Tetracyclic pyridone compounds as antivirals Xianming Jin, Patrick Lee, Peichao Lu, Joseph Michael Young 2017-12-19
9815804 Isoxazole hydroxamic acid compounds as LpxC inhibitors Xianming Jin, Subramanian Karur, Guillaume Lapointe, Ann Marie Madera, Zachary K. Sweeney 2017-11-14
9718792 Isoxazoline hydroxamic acid derivatives as LpxC inhibitors Xianming Jin, Subramanian Karur, Guillaume Lapointe, Patrick Lee, Zachary K. Sweeney 2017-08-01
9637482 Isoxazoline hydroxamic acid derivatives as LpxC inhibitors Xianming Jin, Subramanian Karur, Guillaume Lapointe, Patrick Lee, Zachary K. Sweeney 2017-05-02
9566312 Cyclic peptides and use as medicines Subramanian Karur, Xiaolin Li, Peichao Lu, Wosenu Mergo, Alexey Rivkin +4 more 2017-02-14
9549916 Isoxazole hydroxamic acid compounds as LpxC inhibitors Xianming Jin, Subramanian Karur, Guillaume Lapointe, Ann Marie Madera, Zachary K. Sweeney 2017-01-24